Cosmetic / breast neoplasms

Growth factor complexes and modulation of cell migration and growth

只有注册用户可以翻译文章

登陆注册

FIELD OF THE INVENTION THIS INVENTION relates to protein complexes having respective domains that enable binding to and activation of both a growth factor receptor, such as the type 1 insulin-like growth factor receptor, and an integrin receptor for vitronectin or fibronectin. In particular

Synthetic chimeric proteins comprising epidermal growth factor and vitronectin

只有注册用户可以翻译文章

登陆注册

FIELD OF THE INVENTION This invention relates to protein complexes having respective domains that enable binding to and activation of both a growth factor receptor, such as the type 1 insulin-like growth factor receptor, and an integrin receptor for vitronectin or fibronectin. In particular

Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-d- ione structural scaffold, their biological activity, and uses thereof

只有注册用户可以翻译文章

登陆注册

TECHNICAL FIELD The present invention relates to compounds with biological activity and pharmaceutical and cosmetic formulations thereof, their derivatives and methods of use, more specifically the present invention includes compounds with at least one (substituted phenyl)-propenal moiety and their

Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyI)-4,4-disubstituted-hepta-1,6-diene-3,5-d- ione structural scaffold, their biological activity, and uses thereof

只有注册用户可以翻译文章

登陆注册

TECHNICAL FIELD The present invention relates to compounds with biological activity and pharmaceutical and cosmetic formulations thereof, their derivatives and methods of use, more specifically the present invention includes compounds with at least one (substituted phenyl)-propenal moiety and their

Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-d- ione structural scaffold, their biological activity, and uses thereof

只有注册用户可以翻译文章

登陆注册

TECHNICAL FIELD The present invention relates to compounds with biological activity and pharmaceutical and cosmetic formulations thereof, their derivatives and methods of use, more specifically the present invention includes compounds with at least one (substituted phenyl)-propenal moiety and their

Fibronectin: growth factor chimeras

只有注册用户可以翻译文章

登陆注册

CROSS-REFERENCE TO RELATED APPLICATIONS The present invention is a U.S. National Stage under 35 USC 371 patent application, claiming priority to Serial No. PCT/AU2010/001613, filed on 30 Nov. 2010, which claims priority from U.S. patent application Ser Nos. 12/627,647, filed on 30 Nov. 2009 and

Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof

只有注册用户可以翻译文章

登陆注册

TECHNICAL FIELD The present invention relates to compounds with biological activity and pharmaceutical and cosmetic formulations thereof, their derivatives and methods of use, more specifically the present invention includes compounds with at least one (substituted phenyl)-propenal moiety and their

Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof

只有注册用户可以翻译文章

登陆注册

TECHNICAL FIELD The present invention relates to compounds with biological activity and pharmaceutical and cosmetic formulations thereof, their derivatives and methods of use, more specifically the present invention includes compounds with at least one (substituted phenyl)-propenal moiety and their

Implantable illuminator for photodynamic therapy of the breast and method

只有注册用户可以翻译文章

登陆注册

1. Field of the Invention The invention relates to a light delivery device for uniformly illuminating the nipple and surrounding tissue of a breast. 2. Prior Art Ductile carcinoma in situ (DCIS) is the most common form of breast cancer. The treatment of choice for DCIS depends upon the stage of

Nipple illuminator for photodynamic therapy

只有注册用户可以翻译文章

登陆注册

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to a light delivery device for uniformly illuminating the nipple and surrounding tissue of a breast. 2. Prior Art Ductile carcinoma in situ (DCIS) is the most common form of breast cancer. The treatment of choice for DCIS

cosmetic/breast neoplasms

Growth factor complexes and modulation of cell migration and growth

Synthetic chimeric proteins comprising epidermal growth factor and vitronectin

Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-d- ione structural scaffold, their biological activity, and uses thereof

Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyI)-4,4-disubstituted-hepta-1,6-diene-3,5-d- ione structural scaffold, their biological activity, and uses thereof

Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-d- ione structural scaffold, their biological activity, and uses thereof

Fibronectin: growth factor chimeras

Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof

Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof

Implantable illuminator for photodynamic therapy of the breast and method

Nipple illuminator for photodynamic therapy

科学支持的最完整的草药数据库